Literature DB >> 35629159

Personalized Care and Treatment Compliance in Chronic Conditions.

Júlio Belo Fernandes1,2, Fábio Teixeira3,4,5,6, Catarina Godinho1,2.   

Abstract

Chronic diseases are commonly defined as conditions that last one year or more and require ongoing medical attention, limit activities of daily living, or both [...].

Entities:  

Year:  2022        PMID: 35629159      PMCID: PMC9147940          DOI: 10.3390/jpm12050737

Source DB:  PubMed          Journal:  J Pers Med        ISSN: 2075-4426


Chronic diseases are commonly defined as conditions that last one year or more and require ongoing medical attention, limit activities of daily living, or both [1]. These include, for example, diabetes, cancer, and cardiovascular and neurodegenerative disorders. Such diseases are growing at an alarming rate, especially in the aging population, and are the leading causes of death and disability for adults in developed countries [2]. Living with a chronic condition can be stressful because it changes patients’ lives, distressing their physical or/and mental health or threatening their survival [3]. Nevertheless, people are able to take steps to cope with these new situations, manage their condition, and maintain a good quality of life. People who have chronic diseases spend a significant amount of time in self-management in out-of-hospital environments, in their homes, and in their community settings. These patients have different disease statuses and management requirements. Medicine and healthcare have been profoundly transformed as a result of technological progress along with clinical research achievements, resulting in an increased disease-management capacity [4]. Over time, medicine and healthcare models have evolved towards a practice that is technically feasible, economically valuable [4,5], and culturally, ethically, and socially accepted. In this evolution, personalized care could be the key. It represents an opportunity to improve care for all individuals from a singular or collective point of view that holds promise for the prevention and treatment of diseases. The development of personalized care implies strong involvement and commitment from society. Researchers and policymakers must analyze the potential effect of personalized care approaches within healthcare and recommend reorganization of services, infrastructures, regulations, and policies for personalized care to become truly embedded/implemented in healthcare systems [4]. Additionally, patients, caregivers, family, and healthcare providers identify and discuss problems caused by or related to the patient’s condition and then develop plans and goals to empower patients and their families. A personalized care approach could greatly benefit patients with chronic conditions given its impact on aspects of physical health, mental health, and the ability to self-manage conditions. New approaches that allow for the development of personalized care and improvement of overall treatment adherence should be strongly encouraged by healthcare providers. With this editorial and Special Issue focusing on personalized care and treatment compliance in chronic conditions, we aimed to stimulate the research community to continue producing evidence that supports the positive effects of a personalized care approach on the diagnosis and treatment of chronically ill patients. The accepted topics included a variety of research studies, from study protocols [6] to original qualitative [7,8,9] and quantitative studies [10,11,12,13,14,15,16,17]. Additionally, review protocols [18,19] and literature reviews [20,21,22,23] were included, covering different areas of care, from studies addressing ageism [6] or stigma [17] to a personalized approach to diagnosing and managing ischemic stroke [16]. We highlighted the importance of recognizing that in order to enhance healthcare delivery, all stakeholders involved in providing care must actively partner with patients and families to enable changes in the care process, obtaining higher patient satisfaction and better health outcomes. Therefore, studies involving family caregivers, which are central to delivering better healthcare, were also considered and published in the Special Issue. Several internationally renowned research groups contributed with research. We highlight two studies in particular. The first study reported on a novel boot-camp program to help guide personalized exercise in people with Parkinson’s disease. This study shows the program’s acceptability and usefulness regarding participation in a PD-personalized educational and exercise boot-camp program. This program was considered a valuable example of personalized care used to better influence patients’ exercise habits [15]. Second, we highlight a study aiming to assess the effect of virtual-reality-based therapy to reduce the impact of fibromyalgia syndrome in outcomes such as pain, dynamic balance, aerobic capacity, fatigue, quality of life, anxiety, and depression. The findings demonstrated that virtual-reality-based therapy can effectively reduce pain, fatigue, anxiety, and depression and increase dynamic balance, aerobic capacity, and quality of life in women with fibromyalgia syndrome [21]. Overall, 19 articles were published, all with a common aim of increasing knowledge in the field of personalized care.
  20 in total

Review 1.  Adherence to Therapy in Glaucoma Treatment-A Review.

Authors:  Alexandra-Cătălina Zaharia; Otilia-Maria Dumitrescu; Mădălina Radu; Roxana-Elena Rogoz
Journal:  J Pers Med       Date:  2022-03-22

2.  Rehabilitation Nurse's Perspective on Transitional Care: An Online Focus Group.

Authors:  Rita Pedrosa; Óscar Ferreira; Cristina Lavareda Baixinho
Journal:  J Pers Med       Date:  2022-04-05

3.  Health Promotion and Disease Prevention in the Elderly: The Perspective of Nursing Students.

Authors:  Rogério Ferreira; Cristina Lavareda Baixinho; Óscar Ramos Ferreira; Ana Clara Nunes; Teresa Mestre; Luís Sousa
Journal:  J Pers Med       Date:  2022-02-18

4.  Assessment of Sleep among Patients with Chronic Liver Disease: Association with Quality of Life.

Authors:  Oana-Mihaela Plotogea; Gina Gheorghe; Madalina Stan-Ilie; Gabriel Constantinescu; Nicolae Bacalbasa; Simona Bungau; Camelia Cristina Diaconu
Journal:  J Pers Med       Date:  2021-12-20

Review 5.  The SGLT-2 Inhibitors in Personalized Therapy of Diabetes Mellitus Patients.

Authors:  Mariana Cornelia Tilinca; Robert Aurelian Tiuca; Ioan Tilea; Andreea Varga
Journal:  J Pers Med       Date:  2021-11-25

Review 6.  Bibliometric Analysis of the Informal Caregiver's Scientific Production.

Authors:  Bruno Ferreira; Ana Diz; Paulo Silva; Luís Sousa; Lara Pinho; César Fonseca; Manuel Lopes
Journal:  J Pers Med       Date:  2022-01-06

7.  Addressing Ageism-Be Active in Aging: Study Protocol.

Authors:  Júlio Belo Fernandes; Catarina Ramos; Josefa Domingos; Cidália Castro; Aida Simões; Catarina Bernardes; Jorge Fonseca; Luís Proença; Miguel Grunho; Paula Moleirinho-Alves; Sérgio Simões; Diogo Sousa-Catita; Diana Alves Vareta; Catarina Godinho
Journal:  J Pers Med       Date:  2022-02-25

8.  Personalised Approach to Diagnosing and Managing Ischemic Stroke with a Plasma-Soluble Urokinase-Type Plasminogen Activator Receptor.

Authors:  Katarzyna Śmiłowska; Marek Śmiłowski; Robert Partyka; Danuta Kokocińska; Przemysław Jałowiecki
Journal:  J Pers Med       Date:  2022-03-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.